FibroGen Inc
LSE:0IL8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
FibroGen Inc
LSE:0IL8
|
US |
|
Thales SA
PAR:HO
|
FR |
|
A
|
Atara Biotherapeutics Inc
F:AT2
|
US |
|
Banca Monte dei Paschi di Siena SpA
OTC:BMDPF
|
IT |
|
TUI AG
OTC:TUIFF
|
DE |
|
A
|
Automotive Stampings and Assemblies Ltd
BSE:520119
|
IN |
|
E
|
Elisa Oyj
DUS:EIA
|
FI |
|
T
|
TX Group AG
OTC:TDAAF
|
CH |
|
Funko Inc
NASDAQ:FNKO
|
US |
|
Oculis Holding AG
F:CR5
|
CH |
|
L
|
Lagardere SA
DUS:LAG
|
FR |
|
R
|
Roku Inc
F:R35
|
US |
|
H
|
Harmony Gold Mining Company Ltd
DUS:HAM1
|
ZA |
|
A
|
Air Products and Chemicals Inc
DUS:AP3
|
US |
|
GBM Resources Ltd
F:36G
|
AU |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
DUS:ME9
|
IT |
|
L
|
Legal & General Group PLC
DUS:LGI
|
UK |
|
G
|
Graphisoft Park SE Ingatlanfejleszto Europai Rt
F:GUV
|
HU |
Wall St Price Targets
0IL8 Price Targets Summary
FibroGen Inc
According to Wall Street analysts, the average 1-year price target for
0IL8 is 40.34 USD with a low forecast of 35.85 USD and a high forecast of 45.79 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0IL8's stock price target?
Price Target
40.34
USD
According to Wall Street analysts, the average 1-year price target for
0IL8 is 40.34 USD with a low forecast of 35.85 USD and a high forecast of 45.79 USD.
What is the Revenue forecast for FibroGen Inc?
Projected CAGR
-32%
Over the last 11 years, the compound annual growth rate for Revenue has been -11%. The projected CAGR for the next 4 years is -32%.